Automated technology streamlines astatine-211 production for cancer therapy

Astatine-211 (At-211) is one of a handful of promising alpha emitting radioisotopes for cancer therapy.

NJ judge tosses Novartis’ IRA lawsuit in another win for government

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

October 19, 2024

Alentis nabs $181M to broaden Claudin’s scope in ADCs

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 13, 2024

VR Headsets in Cath Lab; ICDs & Driving Rules; How Cardiologist Got to Space

A look at the feasibility of coronary angiography and angioplasty procedures using the Meta Quest 3 virtual reality (VR) headset. (European Heart Journal) FDA approved

October 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.